Ally Bridge Group (ABG), a China-centered healthcare investor, has completed a Series A investment, as the first part of a total of $50 million raise, in Quantum Surgical, an innovative surgical robotics company in France.

Quantum Surgical is developing next-generation robotic solutions for minimally invasive cancer therapies. Quantum's predecessor company Medtech SA, a leading French neurosurgical robotics company, was acquired by global orthopaedics giant Zimmer Biomet in 2016 after an investment from ABG in 2015.

Lifetech Scientific, a leading innovative medtech company in China, has also participated in the investment through its joint venture with ABG and will collaborate with Quantum Surgical in China market.